107 related articles for article (PubMed ID: 9083772)
41. Incidence of chickenpox in adults and recruitment of plasma donors for manufacture of zoster immunoglobulin.
MacInnes DC; Cuthbertson B; Crawford RJ
Br Med J (Clin Res Ed); 1986 Nov; 293(6558):1348. PubMed ID: 3024773
[No Abstract] [Full Text] [Related]
42. Susceptibility to varicella in childbearing age women, Central Italy: is there a need for vaccinating this population group?
Alfonsi V; Montomoli E; Manini I; Alberini I; Gentile C; Rota MC; Ciofi degli Atti ML
Vaccine; 2007 Aug; 25(32):6086-8. PubMed ID: 17629374
[TBL] [Abstract][Full Text] [Related]
43. Use of statistical models for evaluating antibody response as a correlate of protection against varicella.
Chan IS; Li S; Matthews H; Chan C; Vessey R; Sadoff J; Heyse J
Stat Med; 2002 Nov; 21(22):3411-30. PubMed ID: 12407681
[TBL] [Abstract][Full Text] [Related]
44. Neonatal varicella exposure risk score (NeVERS).
Rathore MH; Gordon VE; Garrison RD
Am J Infect Control; 1993 Jun; 21(3):163-4. PubMed ID: 8393636
[No Abstract] [Full Text] [Related]
45. Interferon-gamma release assay: a simple method for detection of varicella-zoster virus-specific cell-mediated immunity.
Otani N; Baba K; Okuno T
J Immunol Methods; 2009 Dec; 351(1-2):71-4. PubMed ID: 19818791
[TBL] [Abstract][Full Text] [Related]
46. Varicella zoster virus in health care workers in northern Israel: seroprevalence and predictive value of history of varicella infection.
Chazan B; Colodner R; Teitler N; Chen Y; Raz R
Am J Infect Control; 2008 Aug; 36(6):436-8. PubMed ID: 18675150
[TBL] [Abstract][Full Text] [Related]
47. MMA warns against "pox parties".
Minn Med; 2012 Feb; 95(2):28. PubMed ID: 22474890
[No Abstract] [Full Text] [Related]
48. Re-infection with primary varicella zoster in older people.
Gunawardena I; Attygalle T
Age Ageing; 2008 Mar; 37(2):235. PubMed ID: 18349019
[No Abstract] [Full Text] [Related]
49. Varicella pneumonitis: immunodiagnosis with a monoclonal antibody.
Weigle KA; Grose C
J Pediatr; 1984 Aug; 105(2):265-9. PubMed ID: 6205128
[No Abstract] [Full Text] [Related]
50. Critical prevalence of antibodies minimizing vaccination costs for hepatitis A, hepatitis B, varicella, measles and tetanus in adults and adolescents in Catalonia, Spain.
Plans-Rubió P
Vaccine; 2004 Sep; 22(29-30):4002-13. PubMed ID: 15364450
[TBL] [Abstract][Full Text] [Related]
51. Comparison of the performance of the LIAISON VZV-IgG and VIDAS automated enzyme linked fluorescent immunoassays with reference to a VZV-IgG time-resolved fluorescence immunoassay and implications of choice of cut-off for LIAISON assay.
Maple PA; Rathod P; Smit E; Gray J; Brown D; Boxall EH
J Clin Virol; 2009 Jan; 44(1):9-14. PubMed ID: 18823815
[TBL] [Abstract][Full Text] [Related]
52. Severe chickenpox during treatment with corticosteroids. Latex assay shows false negatives.
Bendig J; Meurisse V; Chambers S
BMJ; 1995 Feb; 310(6975):327-8. PubMed ID: 7866186
[No Abstract] [Full Text] [Related]
53. Herpes zoster: new insights provide an important wake-up call for management of nosocomial transmission.
Breuer J
J Infect Dis; 2008 Mar; 197(5):635-7. PubMed ID: 18260760
[No Abstract] [Full Text] [Related]
54. A role for genetics in the immune response to the varicella vaccine.
Klein NP; Fireman B; Enright A; Ray P; Black S; Dekker CL;
Pediatr Infect Dis J; 2007 Apr; 26(4):300-5. PubMed ID: 17414391
[TBL] [Abstract][Full Text] [Related]
55. Varicella immunogenicity with 1- and 2-dose regimens of measles-mumps-rubella-varicella vaccine.
Shinefield HR; Black S; Kuter BJ
J Infect Dis; 2008 Mar; 197 Suppl 2():S152-5. PubMed ID: 18419390
[TBL] [Abstract][Full Text] [Related]
56. Varicella susceptibility and vaccine use among young adults enlisting in the United States Navy.
Ryan MA; Smith TC; Honner WK; Gray GC
J Med Virol; 2003; 70 Suppl 1():S15-9. PubMed ID: 12627481
[TBL] [Abstract][Full Text] [Related]
57. Successful vaccination against varicella zoster virus prior to kidney transplantation.
Geel A; Zuidema W; van Gelder T; van Doornum G; Weimar W
Transplant Proc; 2005 Mar; 37(2):952-3. PubMed ID: 15848586
[TBL] [Abstract][Full Text] [Related]
58. The optimization and validation of the glycoprotein ELISA assay for quantitative varicella-zoster virus (VZV) antibody detection.
Hammond O; Wang Y; Green T; Antonello J; Kuhn R; Motley C; Stump P; Rich B; Chirmule N; Marchese RD
J Med Virol; 2006 Dec; 78(12):1679-87. PubMed ID: 17063506
[TBL] [Abstract][Full Text] [Related]
59. A longitudinal study of varicella immunity in pediatric renal transplant recipients.
Trachtman H; Hammerschlag MR; Tejani A; Steinberg S; Gershon AA
J Infect Dis; 1986 Aug; 154(2):335-7. PubMed ID: 3014014
[No Abstract] [Full Text] [Related]
60. Immunity to varicella zoster virus in young Israeli adults.
Avrahami-Heller Y; Cohen D; Orr N; Slepon R; Ashkenazi I; Danon YL
Isr Med Assoc J; 2000 Mar; 2(3):196-9. PubMed ID: 10774265
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
